drugset / Trial / NCT03627117

Influence of CBD on Episodic Memory in Healthy Subjects

NCT03627117

Completed 39 enrolled University of Basel
RandomizedCrossoverDouble-blindBasic science

Summary

Placebo controlled, randomized, double blind, cross-over design. Single vape of 0.25ml 5% CBD e-liquid (12.5mg CBD) and single vape of 0.25ml e-liquid, tastes like lemon and madeleine. 15min vape time each. A total of 34 participants, equal number of male and female. There will be replacement of Drop-Outs until data from 34 participants are completed. The primary endpoint will be performance in a verbal memory task. The secondary endpoint will be performance in a working memory test.

Timeline

Start
2018-08-13
Primary completion
2018-12-08
Completion
2018-12-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Cannabidiol Other / unclassified 12.5 mg Inhaled

Indications

No indication recorded.